Christopher Simms
Vermögen: - $ am 31.08.2026
Vermögen: - $ am 31.08.2026
Christopher Simms is Chief Commercial & Business Officer at 4D Molecular Therapeutics, Inc. starting in 2025.
Formerly, Mr. Simms was Chief Commercial Officer & Senior Vice President at IVERIC bio, Inc. Education includes an MBA from York University and an undergraduate degree from Memorial University of Newfoundland.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.03.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Corporate Officer/Principal | 25.09.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| IVERIC BIO, INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
York University
York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Memorial University of Newfoundland
Memorial University of Newfoundland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVERIC bio, Inc.
IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen